A detailed history of Ashton Thomas Private Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 81,141 shares of AMGN stock, worth $25.2 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
81,141
Previous 65,691 23.52%
Holding current value
$25.2 Million
Previous $18.9 Billion 21.93%
% of portfolio
1.32%
Previous 1.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$268.87 - $324.56 $4.15 Million - $5.01 Million
15,450 Added 23.52%
81,141 $23.1 Billion
Q4 2023

Apr 19, 2024

BUY
$255.7 - $288.46 $50,117 - $56,538
196 Added 0.3%
65,691 $18.9 Billion
Q3 2023

Apr 19, 2024

BUY
$218.65 - $271.46 $2.5 Million - $3.1 Million
11,438 Added 21.16%
65,495 $17.6 Billion
Q2 2023

Apr 22, 2024

BUY
$214.27 - $253.37 $1.39 Million - $1.64 Million
6,472 Added 11.09%
64,807 $14.4 Billion
Q1 2023

Apr 22, 2024

SELL
$225.79 - $275.2 $5.15 Million - $6.28 Million
-22,806 Reduced 28.11%
58,335 $14.1 Billion
Q4 2022

Apr 19, 2024

SELL
$229.03 - $291.01 $47,867 - $60,821
-209 Reduced 0.39%
54,057 $14.2 Billion
Q3 2022

Apr 19, 2024

SELL
$224.46 - $253.15 $13,467 - $15,189
-60 Reduced 0.11%
54,266 $12.2 Billion
Q2 2022

Apr 19, 2024

BUY
$230.71 - $256.74 $69,213 - $77,022
300 Added 0.56%
54,326 $13.2 Billion
Q1 2022

Apr 19, 2024

BUY
$219.27 - $242.57 $1.04 Million - $1.15 Million
4,742 Added 9.62%
54,026 $13.1 Billion
Q4 2021

Apr 19, 2024

BUY
$198.88 - $227.6 $400,146 - $457,931
2,012 Added 4.26%
49,284 $11.1 Billion
Q3 2021

Apr 19, 2024

BUY
$212.27 - $248.7 $492,466 - $576,984
2,320 Added 5.16%
47,272 $10.1 Billion
Q2 2021

Apr 19, 2024

BUY
$233.58 - $259.14 $547,511 - $607,424
2,344 Added 5.5%
44,952 $11 Billion
Q1 2021

Apr 19, 2024

BUY
$221.91 - $258.6 $992,603 - $1.16 Million
4,473 Added 11.73%
42,608 $10.6 Billion
Q4 2020

Apr 19, 2024

BUY
$216.38 - $257.67 $7.31 Million - $8.7 Million
33,765 Added 772.65%
38,135 $8.77 Billion
Q3 2020

Apr 19, 2024

SELL
$234.65 - $260.95 $1.09 Million - $1.21 Million
-4,626 Reduced 51.42%
4,370 $1.11 Billion
Q2 2020

Apr 19, 2024

BUY
$197.81 - $242.74 $50,045 - $61,413
253 Added 2.89%
8,996 $2.12 Billion
Q1 2020

Apr 19, 2024

BUY
$182.24 - $241.7 $779,804 - $1.03 Million
4,279 Added 95.86%
8,743 $1.77 Billion
Q4 2019

Apr 19, 2024

BUY
$189.21 - $243.2 $418,343 - $537,715
2,211 Added 98.14%
4,464 $1.08 Billion
Q3 2019

Apr 19, 2024

SELL
$174.11 - $208.62 $2,611 - $3,129
-15 Reduced 0.66%
2,253 $436 Million
Q2 2019

Apr 19, 2024

BUY
$166.7 - $195.41 $135,527 - $158,868
813 Added 55.88%
2,268 $418 Million
Q1 2019

Apr 19, 2024

BUY
$180.87 - $203.88 $263,165 - $296,645
1,455 New
1,455 $276 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Ashton Thomas Private Wealth, LLC Portfolio

Follow Ashton Thomas Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.